Skip to content
★ Sign in to follow
JS

Johan Strömqvist

Board Director
Membre du Conseil
Newbury Pharmaceuticals AB
Insider activity · 24 months4 buys4 salesCumulative net flow
Total declarations
9
Company
1
▲ Purchases (5 ops.)
€7,667
▼ Sales (4 ops.)
€7,206

Latest filing published 29 Apr 2025 for Newbury Pharmaceuticals AB, €1,416.

Filing timeline

BuySale
Johan Strömqvist

Insider track record

Disclosed buys
5
Disclosed sells
4
Signal history

Closed purchases

Market purchases
5
Positive at T+90
0%
Median T+90
-16.8%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Johan Strömqvist: trading record in brief

All filings by Johan Strömqvist on record concern Newbury Pharmaceuticals AB, in the capacity of board member. The record holds 9 filings, for trades running from 15 February 2024 to 29 April 2025.

The open-market side counts 5 purchases for €7,667 alongside 4 sales for €7,206. Taken together, the purchases exceed the sales by €462. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2025: 3 purchases and 4 sales on the market.

The median purchase comes to €1,416.

The record was last updated on 29 April 2025 with an open-market purchase (€1,416) in Newbury Pharmaceuticals AB. Half of the filings or more reach the Finansinspektionen feed on the day of the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Companies and markets linked to Johan Strömqvist

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total

9 of 9 declarations